Skip to main content
. 2015 Jan 29;6(1):e1626. doi: 10.1038/cddis.2014.586

Figure 7.

Figure 7

LMP2 knockdown by shRNA reduced activation of astrocytes and microglia after MCAO. Following MCAO, GFAP and OX42 immunoreactivities were evident in the right cortex and striatum in ischemic animals receiving control-ShRNA compared with sham-operated control animals. In contrast, the GFAP and OX42 immunoreactivities were significantly reduced in ischemic animals receiving LMP2-shRNA (*P<0.001, compared with the sham-operated controls; #P<0.001 compared with the cont-shRNA group). Scale bars=50 μm. Five rats in each group were used for immunofluorescent assays (n=5)